Srinivasan, ShylajaO'Rourke, JuliaBersche Golas, SaraNeumeyer, AnnMisra, Madhusmita2016-05-022016Srinivasan, Shylaja, Julia O'Rourke, Sara Bersche Golas, Ann Neumeyer, and Madhusmita Misra. 2016. “Calcium and Vitamin D Supplement Prescribing Practices among Providers Caring for Children with Autism Spectrum Disorders: Are We Addressing Bone Health?” Autism Research and Treatment 2016 (1): 6763205. doi:10.1155/2016/6763205. http://dx.doi.org/10.1155/2016/6763205.2090-1925http://nrs.harvard.edu/urn-3:HUL.InstRepos:26859987Children with autism spectrum disorders (ASD) have several risk factors for low bone mineral density. The gluten-free, casein-free (GFCF) diet is a complementary therapy sometimes used in ASD that raises concerns for the adequacy of calcium and vitamin D intake. This study evaluated the prescribing practices of calcium and vitamin D supplements and the practice of checking 25-hydroxy vitamin D (25(OH)D) levels by providers in 100 children with ASD, 50 of whom were on the GFCF diet. Fifty-two percent and 46% of children on the GFCF diet were on some form of vitamin D and calcium supplements, respectively, compared to 18% and 14% of those not on this diet. Twenty-four percent of children in the GFCF group had a documented 25(OH)D level compared to none in the non-GFCF group. The data highlight a gap in calcium and vitamin D supplement prescribing practices among providers caring for children with ASD as well as a gap in the practice of checking 25(OH)D levels.en-USJournal Article2016-05-0210.1155/2016/6763205